Background/Aims: To investigate pre- and postoperative expression and alterations in the indices of peripheral blood lymphocytes (PBL) CD25 and Ki67 in 32 patients with renal cell carcinoma (RCC) who underwent unilateral radical nephrectomy. We investigated the relationship between the above parameters in PBL and CD8+Ki67+ T cells infiltrated in tumor cells. Patients and Methods: Blood samples were collected preoperatively and on postoperative day 7 (POD7). The PBL CD25 and Ki67 indices were detected by flow cytometry in 32 patients with RCC and in 16 healthy individuals. We conducted double immunohistochemistry for CD8 and Ki67 in tumoral, peritumoral and normal kidney tissues. Results: The PBL CD25 and Ki67 indices on POD7 were higher than their preoperative levels (CD25: 21.37 ± 4.66 vs. 20.30 ± 6.23%; Ki67: 21.92 ± 16.08 vs. 17.05 ± 9.87%), with no significance (p = 0.397 and 0.076, respectively). The pre- and postoperative PBL CD25 and Ki67 indices were significantly higher in patients than in the control group (where they were 14.72 ± 5.40 and 7.50 ± 5.25, respectively, p < 0.01). A negative correlation was observed between the level of the PBL CD25 index on POD7 and the expression of CD8+Ki67+ T cells infiltrated in tumor cells (r = –0.417 and –0.657, p = 0.017 and 0.000, respectively). Conclusions: The PBL CD25 and Ki67 indices could be useful parameters to evaluate performance status in RCC patients. The data we obtained seemed controversial and puzzling and further investigation is required.

Keywords:
Renal cell carcinoma, CD25, Ki67, Flow cytometry, Immunohistochemistry
This content is only available via PDF.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.